Tuning porosity of macroporous hydrogels enables rapid rates of stress relaxation and promotes cell expansion and migration.
biomimetic scaffolds for tissue regeneration
extracellular matrix
poroelasticity
regulation of cell cycle progression
tissue engineering
Journal
Proceedings of the National Academy of Sciences of the United States of America
ISSN: 1091-6490
Titre abrégé: Proc Natl Acad Sci U S A
Pays: United States
ID NLM: 7505876
Informations de publication
Date de publication:
05 Nov 2024
05 Nov 2024
Historique:
medline:
28
10
2024
pubmed:
28
10
2024
entrez:
28
10
2024
Statut:
ppublish
Résumé
Extracellular matrix (ECM) viscoelasticity broadly regulates cell behavior. While hydrogels can approximate the viscoelasticity of native ECM, it remains challenging to recapitulate the rapid stress relaxation observed in many tissues without limiting the mechanical stability of the hydrogel. Here, we develop macroporous alginate hydrogels that have an order of magnitude increase in the rate of stress relaxation as compared to bulk hydrogels. The increased rate of stress relaxation occurs across a wide range of polymer molecular weights (MWs), which enables the use of high MW polymer for improved mechanical stability of the hydrogel. The rate of stress relaxation in macroporous hydrogels depends on the volume fraction of pores and the concentration of bovine serum albumin, which is added to the hydrogels to stabilize the macroporous structure during gelation. Relative to cell spheroids encapsulated in bulk hydrogels, spheroids in macroporous hydrogels have a significantly larger area and smaller circularity because of increased cell migration. A computational model provides a framework for the relationship between the macroporous architecture and morphogenesis of encapsulated spheroids that is consistent with experimental observations. Taken together, these findings elucidate the relationship between macroporous hydrogel architecture and stress relaxation and help to inform the design of macroporous hydrogels for materials-based cell therapies.
Identifiants
pubmed: 39467139
doi: 10.1073/pnas.2410806121
doi:
Substances chimiques
Hydrogels
0
Alginates
0
Serum Albumin, Bovine
27432CM55Q
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e2410806121Subventions
Organisme : HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
ID : F32DK134115
Organisme : HHS | NIH | National Institute of Biomedical Imaging and Bioengineering (NIBIB)
ID : T32EB016652
Organisme : Harvard MRSEC
ID : DMR-2011754
Organisme : Wellcome Leap HOPE
ID : none
Organisme : SMA Foundation
ID : none
Organisme : SERB-India
ID : MTR/2022/000232
Organisme : SERB-India
ID : CRG/2023/007056-G
Organisme : TCS Foundation
ID : TCS/17/23-24/P49
Déclaration de conflit d'intérêts
Competing interests statement:The authors declare no competing interest.